[Validation of interaction databases in psychopharmacotherapy].
1Vitos Klinik Eichberg, Kloster-Eberbach-Str.4, 65346, Eltville, Deutschland. martina.hahn@vitos-rheingau.de.
This study validated German drug interaction databases, finding MediQ performed best but requires improvement in hit rates for enhanced drug therapy safety.
Area of Science:
- Pharmacology
- Drug Safety
- Health Informatics
Background:
- Drug-drug interaction (DDI) databases are crucial for managing polypharmacy and improving patient safety.
- Existing DDIs databases vary in effectiveness, necessitating clear validation studies.
- No prior validation of German-specific DDI databases existed.
Purpose of the Study:
- To validate German drug interaction databases.
- To assess databases on DDI hit rate, mechanism accuracy, clinical advice, reference quality, and severity scoring.
- To identify the most reliable database for clinical use.
Main Methods:
- Evaluated 36 recent drug interactions (3-5 years) across five German databases.
- Assessed databases for accuracy of interaction mechanisms, provision of clinical advice, citation of primary literature, and interaction severity.
- Quantified the number of correct 'hits' for each database.
Main Results:
- All evaluated databases exhibited limitations in accurately identifying drug interactions, with a maximum hit rate of 67.7%.
- MediQ achieved the highest overall score (104/180 points), followed by PsiacOnline (83 points).
- Other databases, arznei-telegramm®, ifap index®, and ABDA-database, scored lower, indicating significant room for improvement.
Conclusions:
- MediQ demonstrated superior performance among the validated German drug interaction databases.
- Despite its leading position, MediQ requires enhancements in its hit rate to ensure user reliability.
- Improving database accuracy is essential for increasing drug therapy safety in clinical practice.
More Related Videos
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
06:12Virtual Prism Adaptation Therapy: Protocol for Validation in Healthy Adults
Published on: February 12, 2020
Related Concept Videos
Drug Therapy
Antianxiety Medications
Quantitative Aspects of Drug-Receptor Interaction
Pharmacokinetics: Drug–Drug Interactions
Therapeutic Drug Monitoring: Affecting Factors
Drug toxicity: Drug–Drug Interaction
Psychosis: Goals of Pharmacotherapy
